Back to top
more

Eli Lilly and Company (LLY)

(Delayed Data from NYSE)

$85.49 USD

85.49
5,752,074

-0.33 (-0.39%)

Updated Jan 19, 2018 04:00 PM ET

Add to portfolio

3-Hold     3    

B Value | A Growth | A Momentum | A VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.71%
2 Buy 18.12%
3 Hold 9.91%
4 Sell 5.49%
5 Strong Sell 2.29%
S&P 500 9.79%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for LLY

   

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Fiscal Year End for Eli Lilly and Company falls in the month of December.

All items in Millions except Per Share data.

12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Assets          
Cash & Equivalents NA 6,039 4,452 4,827 5,397
Receivables NA 4,766 4,072 3,801 4,023
Notes Receivable NA 0 0 0 0
Inventories NA 3,562 3,446 2,740 2,929
Other Current Assets NA 735 604 812 756
Total Current Assets NA 15,101 12,574 12,180 13,105
Net Property & Equipment NA 8,253 8,054 7,964 7,976
Investments & Advances NA 5,208 3,647 4,569 7,625
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 8,331 9,075 4,642 4,331
Deposits & Other Assets NA 1,914 2,221 7,823 2,213
Total Assets NA 38,806 35,569 37,178 35,249
Liabilities & Shareholders Equity 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Notes Payable NA 1,937 6 2,689 1,013
Accounts Payable NA 1,349 1,338 1,128 1,119
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 119 359 1,560 1,047
Other Current Liabilities NA 7,581 6,526 5,831 5,738
Total Current Liabilities NA 10,987 8,230 11,208 8,917
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 8,368 7,972 5,368 4,200
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 5,371 4,777 5,215 4,491
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 24,725 20,979 21,790 17,608
Shareholders Equity 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 689 691 695 699
Capital Surplus NA 5,641 5,552 5,292 5,050
Retained Earnings NA 16,046 16,012 16,483 16,992
Other Equity NA -8,214 -7,575 -6,990 -5,007
Treasury Stock NA 81 90 91 94
Total Shareholder's Equity NA 14,081 14,590 15,388 17,641
Total Liabilities & Shareholder's Equity NA 38,806 35,569 37,178 35,249
Total Common Equity 0 14,081 14,590 15,388 17,641
Shares Outstanding 1,101.10 1,103.90 1,108.00 1,113.40 1,126.60
Book Value Per Share 0.00 12.76 13.17 13.82 15.66

Fiscal Year End for Eli Lilly and Company falls in the month of December.

All items in Millions except Per Share data.

12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Assets          
Cash & Equivalents NA 6,943 5,434 3,506 6,039
Receivables NA 5,015 4,956 4,614 4,766
Notes Receivable NA 0 0 0 0
Inventories NA 4,407 4,346 4,035 3,562
Other Current Assets NA 1,064 1,010 822 735
Total Current Assets NA 17,428 15,747 12,976 15,101
Net Property & Equipment NA 8,599 8,583 8,426 8,253
Investments & Advances NA 6,149 5,723 5,298 5,208
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 8,637 8,833 8,905 8,331
Deposits & Other Assets NA 2,198 2,061 2,020 1,914
Total Assets NA 43,010 40,947 37,624 38,806
Liabilities & Shareholders Equity 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Notes Payable NA 3,538 2,444 2,609 1,937
Accounts Payable NA 1,200 1,257 1,220 1,349
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 414 236 122 119
Other Current Liabilities NA 7,514 7,357 6,497 7,581
Total Current Liabilities NA 12,667 11,295 10,448 10,987
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 9,927 9,868 7,638 8,368
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 5,614 5,435 5,371
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 28,050 26,777 23,521 24,725
Shareholders Equity 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 689 689 690 689
Capital Surplus NA 5,755 5,686 5,618 5,641
Retained Earnings NA 16,146 15,590 15,877 16,046
Other Equity NA -7,552 -7,719 -8,005 -8,214
Treasury Stock NA 76 76 76 81
Total Shareholder's Equity NA 14,961 14,170 14,104 14,081
Total Liabilities & Shareholder's Equity NA 43,010 40,947 37,624 38,806
Total Common Equity 0 14,961 14,170 14,104 14,081
Shares Outstanding 1,101.10 1,101.10 1,100.90 1,103.30 1,103.90
Book Value Per Share 0.00 13.59 12.87 12.78 12.76